Stay in the loop

Sign up to receive updates

Stay in the loop

Sign up to receive updates

Stay in the loop

Sign up to receive updates

Press Release

Health Canada issues licenses for Contino® medical device for urinary incontinence

bg-4

Life360 Innovations Inc. (Life360 Innovations) has received Class II Health Canada licenses for the Contino® urethral insert, Inserter and Gauge.

Contino® is a self-administered licensed medical device that controls bladder leakage in men. Much more than just a device, Contino® is an integrated solution that includes personalised fitting and support from incontinence specialists, so men can get on with life.

According to the Canadian Continence Foundation, urinary incontinence (UI) affects the lives of more than 1.2 million Canadian men, often as a result of prostate cancer treatments and other medical conditions. Issues with the comfort and safety of existing products, such as diapers, penile clamps, and condom catheters, have left a treatment gap for affected males says Dr. Mike Holloway Vice President Medical Life360 Innovations.

“The Contino® is a clear alternative to diapers and the other management techniques currently available”, says Robert Orr, President & CEO of Life360. “Our made-in-Canada UI solution is discreet, convenient and personalised – because there is no one-size-fits-all approach to managing incontinence.”

Prior to being licensed by Health Canada, Contino® was in development for over ten years and was the subject of a five-year, multi-site Canadian clinical study. Much more than just a device, Contino® is an integrated solution that includes personalised fitting and support from incontinence specialists, so men can get on with life. Life360 Innovations hopes that Contino® will not only help with the physical symptoms of UI, but also with the mental health implications – male UI has been found to be significantly associated with major depression.

“This approach to male UI is a breakthrough” say Dr. Steven Kline, a practicing psychiatrist and clinical professor. “With minimal training, it is straightforward to use, while complications are minimal and easily managed. Overall, the benefits of increased freedom to socialize, attend public functions and travel make this a valuable resource for an expanded lifestyle with much less worry.”

For more information on Contino®, please visit mycontino.com or contact:

Robert Orr, President & CEO
Telephone: +1-604-653-0360
Toll Free North America: +1-833-543-3311

About Life360 Innovations Inc.

Life360 Innovations imagines, manufactures and distributes Health Canada Licensed medical devices under the Contino® brand. For more information on Life360 Innovations, visit life360innovations.com.

Cautionary Disclaimer Regarding Forward-Looking Statements and Information

This news release contains certain forward-looking statements concerning Life360 Innovations Holdings Inc. and its’ wholly owned subsidiaries (collectively, the “Companies”) in future periods. Statements that are not historical fact are “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995 and “forward looking information” as that term is defined in National Instrument 51-102 (“NI 51-102”) of the Canadian Securities Administrators (collectively, “forward-looking statements”). This document contains certain forward-looking statements relating, but not limited to, the Company’s expectations, intentions, plans and beliefs. Forward-looking information can often be identified by forward-looking words such as “anticipate”, “believe”, “expect”, “goal”, “plan”, “intend”, “estimate”, “may”, and “will”, or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions, or statements about future events or performance. Forward-looking information may include estimates of future operations, sales, unit costs, costs of capital projects and the timing of commencement of operations that are based on current expectations that involve a number of business risks and uncertainties.

Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, failure to establish estimated revenues, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required regulatory approvals, inflation, changes in exchange rates, delays in the development of projects and other factors. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from expected results.

Shareholders and prospective investors should be aware that these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements. Shareholders are cautioned not to place undue reliance on forward-looking information. By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and various assumed future events will not occur. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking information whether as a result of new information, future events, or other such factors that affect this information, except as required by law.

Reader Interactions